0001209191-21-015849.txt : 20210302
0001209191-21-015849.hdr.sgml : 20210302
20210302160721
ACCESSION NUMBER: 0001209191-21-015849
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210302
DATE AS OF CHANGE: 20210302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 21703584
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-26
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Chief Accounting Officer
Common Stock
2021-02-26
4
F
0
2218
212.42
D
12666
D
Common Stock
2021-03-01
4
S
0
1026
210.13
D
11640
D
Common Stock
2021-03-01
4
S
0
610
211.45
D
11030
D
Common Stock
2021-03-01
4
S
0
915
212.51
D
10115
D
Common Stock
2021-03-01
4
S
0
231
213.12
D
9884
D
Common Stock
169
I
401(k)
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $210.13 (range $209.93 to $210.77).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $211.45 (range $210.96 to $211.95).
Open market sales reported on this line occurred at a weighted average price of $212.51 (range $211.96 to $212.85).
Open market sales reported on this line occurred at a weighted average price of $213.12 (range $212.96 to $213.27).
/s/ Sabrina Yohai, Attorney-in-Fact
2021-03-02